Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Synovial × pasireotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Pituitary Neoplasms 4 Pancreatic Neoplasms 4 Neuroendocrine Tumors 4 Gastro-enteropancreatic neuroendocrine tumor 3 Carcinoid Tumor 3 Pituitary ACTH Hypersecretion 2 Neoplasms 2 Neoplasm Metastasis 2 Nelson Syndrome 2 Acromegaly 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Sarcoma, Synovial 1 Prolactinoma 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Fistula 1 Neuroectodermal Tumors, Primitive 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1

Interventions

Doxorubicin 14 Cyclophosphamide 13 Ifosfamide 9 fludarabine 8 tazemetostat 5 Radiotherapy 5 pembrolizumab 4 Gemcitabine 4 pegfilgrastim 3 pazopanib 3 cixutumumab 3 Trabectedin 3 Filgrastim 3 Docetaxel 3 sargramostim 2 fludarabine phosphate 2 brostallicin 2 X-Rays 2 Sunitinib 2 Sorafenib 2 Radiation 2 Interferon-gamma 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Dacarbazine 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trofosfamide 1 tremelimumab 1 temsirolimus 1 sotigalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06456359 2025-01-13

PAMSARC

University Hospital Heidelberg

Phase 2 Recruiting

Sarcoma, Synovial, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡